Cart
sales@molnova.com
GLP-1 receptor agonist 9
CAS No. 2401892-71-3
GLP-1 receptor agonist 9( 1H-Benzimidazole-6-carboxylic acid )
Catalog No. M28775 CAS No. 2401892-71-3
1H-Benzimidazole-6-carboxylic acid is a GLP-1 receptor agonist.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 264 | Get Quote |
|
| 10MG | 392 | Get Quote |
|
| 25MG | 655 | Get Quote |
|
| 50MG | 923 | Get Quote |
|
| 100MG | 1228 | Get Quote |
|
| 200MG | 1655 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameGLP-1 receptor agonist 9
-
NoteResearch use only, not for human use.
-
Brief Description1H-Benzimidazole-6-carboxylic acid is a GLP-1 receptor agonist.
-
Description1H-Benzimidazole-6-carboxylic acid is a GLP-1 receptor agonist.
-
In Vitro——
-
In Vivo——
-
Synonyms1H-Benzimidazole-6-carboxylic acid
-
PathwayGPCR/G Protein
-
TargetGlucagon Receptor
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2401892-71-3
-
Formula Weight592.06
-
Molecular FormulaC32H31ClFN3O5
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC[C@@]1(c(ccc(Cl)c2)c2F)Oc(c(C2CCN(Cc3nc(ccc(C(O)=O)c4)c4n3C[C@H]3OCC3)CC2)ccc2)c2O1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Bay 55-9837
Selective VPAC2 receptor agonist (EC50 values are 0.4, 100 and >1000 nM for VPAC2, VPAC1 and PAC1, respectively in a cAMP accumulation assay; IC50 values are 60, 8700 and >10000 nM for VPAC2, VPAC1 and PAC1, respectively in a competition binding assay). Stimulates glucose-dependent insulin secretion in isolated human pancreatic islets. Reduces HIV-1 viral replication and shows cooperative effects when given in conjunction with VPAC1 agonists.
-
GRA Ex-25
A potent glucagon receptor inhibitor with IC50 of 56 and 55 nM for rat and human glucagon receptors.
-
des-His1-[Glu9]-Gluc...
Glucagon receptor antagonist (pA2 = 7.2 for inhibition of glucagon-induced adenylyl cyclase activation in rat liver membranes); displays no agonist activity. Enhances glucose-stimulated pancreatic insulin release in vitro. Blocks added glucagon-induced hyperglycemia in normal rabbits without affecting glycogenolysis in vivo. Also blocks endogenous glucagon-induced hyperglycemia in streptozocin diabetic rats.
